PFE
Pfizer Inc.
Revenue by segment
2025, ended Dec 31, 2025
Earlier:
Segments by fiscal year
| USDLine, in USD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biopharma | 61.2B | 62.4B | 58.2B | 99.8B | 79.6B | 40.7B | 38.0B | — | 35.5B | — | — | — | — | — | — | — | — |
| Other Business Activities | 1.38B | 1.23B | 1.32B | 1.35B | — | — | 2.89B | — | 97M | — | — | 0.25B | 0.23B | 0.23B | — | — | — |
| — | — | — | — | 1.7B | 926M | — | — | 16.9B | 52.8B | 48.9B | 49.4B | 51.4B | 54.4B | 61.0B | 65.2B | 49.3B | |
| Business Innovation | — | — | — | — | 1.73B | — | — | — | — | — | — | — | — | — | — | — | — |
| PC1 | — | — | — | — | — | 926M | — | — | — | — | — | — | — | — | — | — | — |
| Upjohn | — | — | — | — | — | — | — | — | 13.4B | — | — | — | — | — | — | — | — |
| Reconciling Items | — | — | — | — | — | — | — | — | 3.47B | — | — | — | — | — | — | — | — |
| Innovative Health | — | — | — | — | — | — | — | — | — | 29.2B | 26.8B | — | — | — | — | — | — |
| Essential Health | — | — | — | — | — | — | — | — | — | 23.6B | 22.1B | — | — | — | — | — | — |
| Certain Significant Items | — | — | — | — | — | — | — | — | — | — | — | 198M | 132M | — | — | — | — |
| Operating Segments | — | — | — | — | — | — | — | — | — | — | — | — | — | 54.4B | — | — | — |
Global Established Pharmaceutical | — | — | — | — | — | — | — | — | — | — | — | 25.1B | 27.6B | 31.7B | — | — | — |
Global Innovative Pharmaceutical | — | — | — | — | — | — | — | — | — | — | — | 13.9B | 14.3B | 13.8B | — | — | — |
Global Vaccines, Oncology and Consumer Healthcare | — | — | — | — | — | — | — | — | — | — | — | 10.1B | 9.3B | 9.0B | — | — | — |
| Other operating segment and other business activities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.29B | — | — |
| Reportable Segments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 57.7B | 58.5B | 48.7B |
Established Products and Emerging Markets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 18.5B | 18.8B | 13.9B |
Primary Care | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 22.7B | 23.3B | 22.6B |
Specialty Care And Oncology | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 16.6B | 16.4B | 8.9B |
Animal Health and Consumer Healthcare | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.26B |
| Consumer Healthcare and other business activities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 319M | — |
| Other operating segments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 6.32B | — |
| Nutrition and other business activities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 563M |
| Total | 62.6B | 63.6B | 59.6B | 101.2B | 81.3B | 41.7B | 40.9B | 40.8B | 52.5B | 52.8B | 48.9B | 49.6B | 51.6B | 54.7B | 61.0B | 65.2B | 49.3B |
A period with only a total isn't split by segment in the filings.